CS-27349
Chemical compound
Identifiers | |
---|---|
|
|
CAS Number |
|
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard ( EPA ) | |
Chemical and physical data | |
Formula | C 22 H 25 N O 3 |
Molar mass | 351.446 g·mol −1 |
3D model ( JSmol ) | |
|
|
|
CS-27349 , or L -2-α-tropinyl benzilate , is an experimental incapacitating agent . It acts as an antagonist to muscarinic acetylcholine receptors , causing delirium . It has 37% of the potency of the related compound 3-quinuclidinyl benzilate (BZ) in producing peripheral effects, but 85% of the potency in producing central effects. The mean dose required to incapacitate subjects was 1.2 times that of BZ. [1] It has not been in use since the 1970s, and there have been no publications about its effects or long-term toxicology since then. [2]
References
- ↑ Ball JC (2015). "Dual Use Research of Concern: Derivatives of 3-Quinuclidinyl Benzilate" . Military Medical Science Letters . 84 (1): 2–41. doi : 10.31482/mmsl.2015.001 .
- ↑ Assessment of Potential Long-Term Health Effects on Army Human Test Subjects of Relevant Biological and Chemical Agents, Drugs, Medications and Substances (PDF) (Report). Ho-Chunk Technical Solutions Healthcare Division. February 29, 2016. Archived (PDF) from the original on December 25, 2020.
Psychedelics
( 5-HT 2A agonists) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives
( NMDAR antagonists ) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants
( mAChR antagonists ) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
mAChRs |
|
||||
---|---|---|---|---|---|
Precursors
(and prodrugs ) |
|||||